The impact of pharmaceutical innovation on premature cancer mortality in Switzerland, 1995–2012
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1618-7601
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
The impact of pharmaceutical innovation on premature cancer mortality in Switzerland, 1995–2012 ; volume:17 ; number:7 ; day:5 ; month:9 ; year:2015 ; pages:833-854 ; date:9.2016
The European journal of health economics ; 17, Heft 7 (5.9.2015), 833-854, 9.2016
- Urheber
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1007/s10198-015-0725-6
- URN
-
urn:nbn:de:1111-201609018469
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:43 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Lichtenberg, Frank R.
- SpringerLink (Online service)
Ähnliche Objekte (12)
The association between pharmaceutical innovation and both premature mortality and hospital utilization in Switzerland, 1996-2019
The association between pharmaceutical innovation and both premature mortality and hospital utilization in Switzerland, 1996–2019
Premature mortality and poverty measurement
Journal of pharmaceutical innovation
The impact of pharmaceutical innovation on cancer mortality in Mexico, 2003-2013
The impact of pharmaceutical innovation on cancer mortality in Mexico, 2003–2013
Economic impacts of a premature nuclear phase-out in Switzerland
Economic Impacts of a Premature Nuclear Phase-Out in Switzerland
Second generation patents in pharmaceutical innovation
Adverse childhood experiences and premature all-cause mortality
A Mixture-Function Mortality Model: Illustration of the Evolution of Premature Mortality
Leading pharmaceutical innovation : trends and drivers for growth in the pharmaceutical industry
The association between pharmaceutical innovation and both premature mortality and hospital utilization in Switzerland, 1996-2019
The association between pharmaceutical innovation and both premature mortality and hospital utilization in Switzerland, 1996–2019
Premature mortality and poverty measurement
Journal of pharmaceutical innovation
The impact of pharmaceutical innovation on cancer mortality in Mexico, 2003-2013
The impact of pharmaceutical innovation on cancer mortality in Mexico, 2003–2013
Economic impacts of a premature nuclear phase-out in Switzerland
Economic Impacts of a Premature Nuclear Phase-Out in Switzerland
Second generation patents in pharmaceutical innovation
Adverse childhood experiences and premature all-cause mortality
A Mixture-Function Mortality Model: Illustration of the Evolution of Premature Mortality
Leading pharmaceutical innovation : trends and drivers for growth in the pharmaceutical industry
The association between pharmaceutical innovation and both premature mortality and hospital utilization in Switzerland, 1996-2019
The association between pharmaceutical innovation and both premature mortality and hospital utilization in Switzerland, 1996–2019
Premature mortality and poverty measurement
Journal of pharmaceutical innovation
The impact of pharmaceutical innovation on cancer mortality in Mexico, 2003-2013
The impact of pharmaceutical innovation on cancer mortality in Mexico, 2003–2013
Economic impacts of a premature nuclear phase-out in Switzerland
Economic Impacts of a Premature Nuclear Phase-Out in Switzerland
Second generation patents in pharmaceutical innovation
Adverse childhood experiences and premature all-cause mortality
A Mixture-Function Mortality Model: Illustration of the Evolution of Premature Mortality